查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2152400

生物活性創傷護理市場規模、佔有率和趨勢分析報告：按產品、應用、地區和細分市場分類（2026-2033 年）

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally Invasive Surgery), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球生物活性創傷護理市場預計到 2025 年將達到 129 億美元，到 2026 年將成長至 138 億美元，到 2033 年將成長至 228 億美元，2026 年至 2033 年的複合年成長率為 7.4%。

北美市場佔據領先地位，預計2025年將佔全球銷售額的40.0%。主要市場促進因素包括人口老化和糖尿病患者慢性傷口盛行率的上升。市場成長的驅動力還包括對先進傷口管理技術的積極應用、保險報銷和資金籌措，以及對再生醫學和組織工程的投資。

具有促進傷口癒合和支持組織再生能力的生物活性創傷護理產品日益普及，顯著推動了市場成長。生物活性敷料擴大應用於急慢性傷口管理，以維持最佳傷口環境、促進細胞活性並降低感染風險。慢性傷口負擔日益加重，尤其是在老年人和糖尿病患者中，持續推動對先進傷口管理解決方案的需求。根據國際糖尿病聯盟（IDF）第11版《糖尿病地圖集》，到2024年，全球65至99歲人群中將有超過1.583億人患有糖尿病，老年人群的糖尿病盛行率將達到23.7%。

糖尿病盛行率的不斷上升導致糖尿病足潰瘍、壓瘡和其他慢性傷口的發生率增加，這些傷口通常需要先進的創傷護理干預措施。此外，外科手術的增加、人們對有效傷口管理的認知不斷提高以及創傷護理產品來改善癒合效果、減少併發症並縮短復原時間。隨著人們對先進傷口管理和患者預後的關注度不斷提高，預計所有醫療機構對生物活性創傷護理解決方案的需求都將增加。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：生物活性創傷護理市場：變數、趨勢與範圍

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 生物活性創傷護理市場分析工具

第4章：生物活性創傷護理市場：產品具體估算與趨勢分析

  • 生物活性創傷護理市場：產品特定趨勢分析，2025 年和 2033 年
  • 濕性創傷護理
  • 抗菌創傷護理
  • 活性敷料

第5章：生物活性創傷護理市場：按應用分類的估算與趨勢分析

  • 生物活性創傷護理市場：基於應用的趨勢分析，2025 年和 2033 年
  • 一般外科
  • 微創手術

第6章：生物活性創傷護理市場：區域估算與趨勢分析

  • 2025 年和 2033 年生物活性創傷護理產品的區域市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • B. Braun SE
    • Essity Health & Medical
    • 3M
    • Convatec Group PLC
    • Covalon Technologies Ltd
    • DermaRite Industries LLC
    • Hollister Incorporated
    • Integra LifeSciences Corporation
    • Johnson & Johnson Services, Inc.
    • Medtronic
    • Monlnlycke Health Care AB
    • Smith+Nephew
簡介目錄
Product Code: GVR-1-68038-081-1

The global bioactive wound care market size was valued at USD 12.9 Billion in 2025 and is projected to grow from USD 13.8 billion in 2026 to USD 22.8 billion by 2033, at a CAGR of 7.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Key market drivers include the increasing prevalence of chronic wounds among the aging population and those with diabetes. The market is driven by strong adoption of advanced wound management technologies, reimbursement and financing, and investments in regenerative medicine and tissue engineering.

The growing adoption of bioactive wound care products due to their ability to accelerate healing and support tissue regeneration is contributing significantly to market growth. Bioactive dressings are increasingly used in the management of chronic and acute wounds because they help maintain an optimal wound environment, promote cellular activity, and reduce the risk of infection. The growing burden of chronic wounds, particularly among elderly patients and individuals with diabetes, continues to support demand for advanced wound management solutions. According to the 11th Edition of the International Diabetes Federation (IDF) Diabetes Atlas, in 2024, over 158.3 million people aged 65-99 years were living with diabetes, representing a prevalence of 23.7% among older adults.

The increasing prevalence of diabetes is contributing to a higher incidence of diabetic foot ulcers, pressure ulcers, and other chronic wounds that often require advanced wound care interventions. In addition, rising surgical procedure volumes, increasing awareness regarding effective wound management, and growing adoption of regenerative healthcare technologies are supporting market expansion. Healthcare providers are increasingly using bioactive wound care products to improve healing outcomes, reduce complications, and shorten recovery periods. As the focus on advanced wound management and patient outcomes continues to strengthen, demand for bioactive wound care solutions is expected to increase across healthcare settings.

Bioactive Wound Care Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels, providing an analysis of the latest industry trends and opportunities in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented global bioactive wound care market report on the basis of product, application, and region.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)

Moist Wound Care

    • Foam
    • Alginate
    • Film
    • Hydrocolloid
    • Hydrogel

Antimicrobial Wound Care

    • Silver Based
    • Non-Silver Based

Active Dressing

    • Biomaterial
    • Skin Substituents
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)

General Surgery

    • Plastic
    • Dermatological
    • Pediatric

Minimally Invasive Surgery

  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioactive Wound Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioactive Wound Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioactive Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioactive Wound Care Market: Product Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Moist Wound Care
    • 4.3.1. Moist Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Foam
        • 4.3.1.1.1. Foam Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Alginate
        • 4.3.1.2.1. Alginate Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Film
        • 4.3.1.3.1. Film Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.4. Hydrocolloid
        • 4.3.1.4.1. Hydrocolloid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.5. Hydrogel
        • 4.3.1.5.1. Hydrogel Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Antimicrobial Wound Care
    • 4.4.1. Antimicrobial Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Silver Based
        • 4.4.1.1.1. Silver Based Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Non-Silver Based
        • 4.4.1.2.1. Non-Silver Based Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Active Dressing
    • 4.5.1. Active Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. Biomaterial
        • 4.5.1.1.1. Biomaterial Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. Skin Substituents
        • 4.5.1.2.1. Skin Substituents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Bioactive Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioactive Wound Care Market: Application Movement Analysis, USD Million, 2025 & 2033
  • 5.3. General Surgery
    • 5.3.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.1. Plastic
        • 5.3.1.1.1. Plastic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.2. Dermatological
        • 5.3.1.2.1. Dermatological Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.3. Pediatric
        • 5.3.1.3.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.3.1.4. Others
        • 5.3.1.4.1. Others General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Minimally Invasive Surgery
    • 5.4.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Bioactive Wound Care Market: Regional Estimates & Trend Analysis

  • 6.1. Bioactive Wound Care Market Share, By Region, 2025 & 2033, USD Million
  • 6.2. North America
    • 6.2.1. North America Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioactive Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Essity Health & Medical
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. 3M
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Convatec Group PLC
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Covalon Technologies Ltd
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. DermaRite Industries LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hollister Incorporated
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Integra LifeSciences Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Johnson & Johnson Services, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Medtronic
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Monlnlycke Health Care AB
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Smith+Nephew
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives